炬申股份(001202.SZ):擬2.5億元投建炬申股份鞏義大宗商品交易交割中心項目
格隆匯12月12日丨炬申股份(001202.SZ)公佈,公司擬在河南省鞏義市設立全資子公司鞏義炬申供應鏈服務有限公司(暫定名,最終以工商部門核准為準),註冊資本為5000萬元人民幣。
公司擬與鞏義市人民政府簽署《炬申鞏義項目投資協議》,在鞏義市投資建設炬申股份鞏義大宗商品交易交割中心項目,並以擬設立的鞏義炬申供應鏈服務有限公司作為項目公司,承接公司在《投資協議》項下的權利義務。該項目預計總投資2.5億元人民幣(含土地購置費),項目規劃建設有色金屬倉儲區、裝卸作業及物流服務區、商貿服務和辦公區三大功能區域,資金來源為公司自有資金或自籌資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.